Catalyst Wire Dossier Catalyst Wire Dossier

Linvemastat

Linvemastat · Foresee Pharmaceuticals Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Linvemastat, covering 2025-10-20 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia) [Phase 2]

See pricing